Reference
Calzolari F, et al. Security profile of biological therapy: Infliximab and adalimumab, a comparison. Digestive and Liver Disease 46 (Suppl. 3): e92-e93, 30 Sep 2014. Available from: URL: http://doi.org/10.1016/j.dld.2014.07.073 [abstract] - Italy
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1531, 16 (2014). https://doi.org/10.1007/s40278-014-5649-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-014-5649-x